NCT06677827View on ClinicalTrials.gov

Effect of Adding Magnesium Sulphate As Adjuvant to Bupivacaine in Ultrasound Guided External Oblique Intercostal Plane Block in Upper Abdominal Cancer Surgery.to Assess the Total Postoperative Opioid Consumption in the First 24 H and Evaluate Post Operative VAS Score

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 1, 2026

Study Completion Date

January 1, 2027

Conditions

Upper Abdominal Cancer Surgery

Interventions

DRUG

Bupivacaine

External Oblique Intercostal plane block technique with 20 ml bupivacaine 0.25% only bilateral

DRUG

Magnesium Sulfate and Bupivacaine 0.125%

External Oblique Intercostal plane block technique with 20 ml bupivacaine 0.25%+200 mg magnesium sulphate bilateral

All Listed Sponsors

lead

Assiut University

OTHER

NCT06677827 - Effect of Adding Magnesium Sulphate As Adjuvant to Bupivacaine in Ultrasound Guided External Oblique Intercostal Plane Block in Upper Abdominal Cancer Surgery.to Assess the Total Postoperative Opioid Consumption in the First 24 H and Evaluate Post Operative VAS Score | Biotech Hunter | Biotech Hunter